Navigation Links
PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma
Date:11/19/2013

PISCATAWAY, N.J., Nov. 19, 2013 /PRNewswire/ -- PBL Assay Science announces the expansion of its assay services portfolio to include 38 different ultra-sensitive biomolecule assays using the Singulex® Erenna® Immunoassay technology.  Based on an innovative single-molecule counting (SMC) technology, these services are designed to provide sub-picogram per ml sensitivity for analytes in human serum or plasma.  The background reduction methodology of this detection service extends the linear dynamic range to over 4 logs, allowing a wide concentration range of biomarker measurement with minimal dilution in many disease states.

"We are proud to offer ultra-sensitive cytokine detection services to researchers around the world," said Dr. Thomas Lavoie, Director of Product Research & Development and Assay Services at PBL.  "The ability to measure basal levels of cytokines and other biomarkers in the femtogram per ml range will enable far deeper analysis of changes in these biomarkers, enhancing our understanding of various diseases and disease therapies, and allowing for earlier project milestone decisions, saving our clients time and money."

The addition of ultra-sensitive cytokine detection services signifies PBL's commitment in providing the best service solutions to meet scientists' assay needs.  It complements the company's single-analyte ELISA, cytokine multiplex ELISA, and cell-based activity assay services that are currently offered in their sample testing and screening catalog.

Ultra-sensitive assay services offered by PBL include detection for cytokines such as human IL-17A, IL-17F, IL-17 A/F heterodimer, IL-6, IL-1alpha, IL-1beta, IL-10, IL-15, TNF-alpha, GLP-1, and biomarkers such as cardiac troponin-I.  For additional information about this technology, view our poster presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference.  To learn more about these services, contact Stephen Parent, the company's Director of Business Development, at sparent@pblbio.com or 1-732-777-9123 ext. 117.

About PBL Assay Science

PBL Assay Science is a major provider of products, services, information, and know-how related to interferons, cytokines, antibodies, ELISAs, and assay solutions.  The company employs state-of-the-art technology in conducting assay services and manufacturing world-class products for scientists around the globe each day. Learn more at pblbio.com.

Contact:

Stephen A. Parent


sparent@pblbio.com


(732) 777-9123 x 117


'/>"/>
SOURCE PBL Assay Science
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of Corporate Headquarters to Waltham
2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
3. Quantum Materials Engineers Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices
4. Sharp Edge Labs and SpectraGenetics Sign Agreement to Provide Better Assays for Studying G-Protein Coupled Receptors
5. Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems
6. IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay
7. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
8. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
9. Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
10. Markteinführung neuer Assays für Magen-Darm Infektionen in Europa
11. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 BiondVax ... CEO, Dr. Ron Babecoff , will be attending the ... City . On Thursday, May 5, Dr. ... conference presented by Joseph Gunner & Co, taking ... BiondVax presentation that Dr. Babecoff will be using is downloadable ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Multiple Myeloma Market ... to their offering.       (Logo: ... Myeloma Market and Competitive Landscape Highlights 2016, ... products, Multiple Myeloma epidemiology, Multiple Myeloma market ...
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... , ... A new collaboration will give more researchers access to the largest ... analytics leader SAS will provide researchers worldwide with data management and analytics tools to ... , The DCRI and SAS share the goal of greater transparency and openness ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, ... same-day LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her ... surgery the same day as her in-office consultation and eye exam. Francesca’s eyesight was ...
(Date:5/4/2016)... ... 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which is renowned ... a free seminar on stem cell injections. The seminar is scheduled for Wednesday, May ... Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. , ...
(Date:5/4/2016)... Lenexa, KS (PRWEB) , ... May 04, 2016 ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps ... life-saving treatments to patients. , Since Transtem’s initial launch, Mediware has continued to ...
Breaking Medicine News(10 mins):